Developing an HPV vaccine to prevent cervical cancer and genital warts

July 5, 2011 By 4 Comments

Bryan JT Source Vaccine and Biologics Research, Merck Research Laboratories, Merck & Co., Inc., West Point, PA, United States. janine_bryan@merck.com Abstract The challenges of the journey from target identification through development of a prophylactic quadrivalent human papillomavirus (HPV) vaccine have been met in Gardasil. Cervical cancer is the second leading cause of cancer-related death in [...]

[Continue reading...]
Filed Under: Gardasil/Silgard Product Info., Human Papillomavirus Research Tagged With: ,

GARDASIL VACCINATION: EVALUATING THE RISKS VERSUS BENEFITS

February 1, 2011 By

By Lucija Tomljenovic, PhD Neural Dynamics Research Group, Dept. of Ophthalmology, University of British Columbia, 828 W. 10th Ave, Vancouver, BC January 2011 All drugs are associated with some risks of adverse reactions and vaccines are no exception. In weighing risks versus benefits, one has to keep in mind that vaccines represent a special category [...]

[Continue reading...]
Filed Under: Gardasil/Silgard Product Info., Human Papillomavirus Research, Vaccine Safety Tagged With:

PATIENT INFORMATION ABOUT GARDASIL

January 15, 2011 By

What important information about GARDASIL should I know? You should continue to get routine cervical cancer screening. GARDASIL may not fully protect everyone who gets the vaccine. GARDASIL will not protect against HPV types that you already have.   Who should not get GARDASIL? You should not get GARDASIL if you have, or have had: [...]

[Continue reading...]
Filed Under: Gardasil / Silgard Injuries, Gardasil/Silgard Product Info., Gardasil/Silgard Reactions, Gardasil/Silgard Vaccine Tagged With: , , , ,

Girls OnGuard: HPV Vaccination Uptake Among African American Adolescent Females

January 15, 2011 By

This study is currently recruiting participants. Verified by Emory University, February 2010 Official Title Overcoming Barriers to Vaccination With GARDASIL in Underserved Girls and Adolescents Purpose African American adolescent females seeking treatment for STIs are an underserved population at increased risk for HPV infection. While GARDASIL is an effective preventive vaccine, vaccination rates are low. [...]

[Continue reading...]
Filed Under: Gardasil / Silgard Injuries, Gardasil/Silgard Clinical Trials, Gardasil/Silgard Product Info., Gardasil/Silgard Vaccine Tagged With: , , ,

Preparing for Adolescent HIV Vaccine Trials in South Africa: (CATSA)

January 15, 2011 By

This study is not yet open for participant recruitment. Verified by Desmond Tutu HIV Centre, July 2009 Official Title Preparing for Adolescent HIV Vaccine Trials in South Africa: a Multi-centre Study to Evaluate Acceptability of the HPV Vaccine in Adolescents Purpose This study will use the licensed HPV vaccine, Gardasil, as a surrogate for an [...]

[Continue reading...]
Filed Under: Gardasil / Silgard Injuries, Gardasil/Silgard Clinical Trials, Gardasil/Silgard Product Info., Gardasil/Silgard Vaccine Tagged With: , , , , ,

Human Papillomavirus (HPV) Vaccine Pilot Project

January 15, 2011 By

Note from SaneVax: Study on barriers to HPV vaccine uptake. Psychological, financial, perception of need? Could it possibly be adverse events?

[Continue reading...]
Filed Under: Gardasil / Silgard Injuries, Gardasil/Silgard Clinical Trials, Gardasil/Silgard Product Info., Gardasil/Silgard Vaccine Tagged With: , , , , ,

Randomized Trial of Alternative HPV Vaccination Schedules in Males in a University Setting

January 15, 2011 By

This study is not yet open for participant recruitment. Verified by University of Pittsburgh, August 2010 Official Title  Randomized Trial of Alternative HPV Vaccination Schedules in Males in a University Setting Purpose The investigators propose a randomized, open label trial of the immunogenicity of HPV vaccine among males 18-24 years old, comparing an on-time administration [...]

[Continue reading...]
Filed Under: Gardasil / Silgard Injuries, Gardasil/Silgard Clinical Trials, Gardasil/Silgard Product Info., Gardasil/Silgard Vaccine Tagged With: , , ,

Immune Response to the Human Papillomavirus Vaccine in Young Women With Inflammatory Bowel Disease

January 15, 2011 By

This study is currently recruiting participants. Verified by Mayo Clinic, July 2010 Official Title: Comparison of Immune Response to the Human Papillomavirus Vaccine in Young Women With and Without Inflammatory Bowel Disease Purpose The Gardasil vaccine, a vaccine targeted towards the human papillomavirus (HPV), has been shown to prevent the transmission of several strains of [...]

[Continue reading...]
Filed Under: Gardasil / Silgard Injuries, Gardasil/Silgard Clinical Trials, Gardasil/Silgard Product Info., Gardasil/Silgard Vaccine Tagged With: , , , ,

GARDASIL Reexamination Study

January 15, 2011 By

This study is currently recruiting participants. Verified by Merck, February 2010 Official Title Re-examination Study for General Vaccine Use to Assess the Safety Profile of GARDASIL in Usual Practice Purpose This survey is conducted for preparing application materials for re-examination under the Pharmaceutical Affairs Laws and its Enforcement Regulation, its aim is to reconfirm the [...]

[Continue reading...]
Filed Under: Gardasil / Silgard Injuries, Gardasil/Silgard Clinical Trials, Gardasil/Silgard Product Info., Gardasil/Silgard Vaccine Tagged With: , , , ,

A Study of V503 in Females 12-26 Years of Age Who Have Previously Received GARDASIL™

January 15, 2011 By

V503 is a multi-valent HPV vaccine still under development by Merck & Co.

[Continue reading...]
Filed Under: Gardasil / Silgard Injuries, Gardasil/Silgard Clinical Trials, Gardasil/Silgard Product Info., Gardasil/Silgard Vaccine Tagged With: , ,